Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Cancer Biology & Therapy|November 20, 2009
Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cellsSalahaldin A Tahir, Sanghee Park, Timothy C Thompson
Cancer Research|October 26, 2011
GLIPR1 suppresses prostate cancer development through targeted oncoprotein destructionLikun Li, Chengzhen Ren, Guang Yang, et al.
Molecular Oncology|January 22, 2013
Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2Likun Li, Guang Yang, Chengzhen Ren, et al.
The Journal of Urology|September 28, 2002
The role of caveolin-1 in androgen insensitive prostate cancerVladimir Mouraviev, Likun Li, Salahaldin A Tahir, et al.
International Journal of Cancer|December 27, 2017
Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer modelsYong Luo, Abul Kalam Azad, Styliani Karanika, et al.
Biochemistry|February 20, 2002
Transcription activation by ultrabithorax Ib protein requires a predicted alpha-helical regionXin-Xing Tan, Sarah Bondos, Likun Li, et al.
Expert Review of Anticancer Therapy|July 13, 2002
Gene therapy for prostate cancerYehoshua Gdor, Terry L Timme, Brian J Miles, et al.
Cancer|February 16, 2005
Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progressionGuang Yang, Terry L Timme, Anna Frolov, et al.
Cancer Biology & Therapy|December 17, 2005
CDC4 gene expression as potential biomarker for targeted therapy in prostate cancerMoon S Koh, Michael Ittmann, Dov Kadmon, et al.
Oncotarget|June 23, 2016
Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancerTheodoros Karantanos, Styliani Karanika, Jianxiang Wang, et al.
Pageof 13